Nephron Pharmaceuticals Plans $313 Million Expansion; Will Create 700+ New Jobs

User Rating :

/ 0

Sunday, 30 October 2011 22:53

ORLANDO, FL – October 28, 2011 – Nephron Pharmaceuticals Corporation today announced expansion plans that involve constructing new pharmaceutical operations in Lexington County, SC. The planned $313 million investment is expected to generate 707 new jobs. The new
pharmaceutical campus will be located a few miles outside of Columbia, SC along Interstates 26 and 77.
“We would like to thank the MOEDC, along with the City of Orlando, Orange County and the State of Florida in their help in assessing the Florida marketplace. However, the decision to expand into South Carolina was based on several reasons, which included insurance concerns, need for geographic diversity of operations, competitive marketplace and state incentives. While the new facilities will be located in South Carolina, Nephron is committed to the Orlando area. We will continue to operate 250,000 square feet of manufacturing, distribution and packaging facilities in the City Of
Orlando. Additionally, we control approximately 60 acres adjacent to our existing operations, where the expansion into biologics/vaccines remains a strong possibility for us,” said Lou Kennedy, CEO of Nephron Pharmaceuticals Corporation.

Nephron Pharmaceuticals Corporation is a global leader in manufacturing generic respiratory medications and employs over 400 Floridians. The company’s products are available to retail pharmacies, hospitals, home care companies, long term care facilities, mail order pharmacies, and various other customers. Nephron Pharmaceuticals is headquartered in Orlando, FL and has distribution centers located in Kentucky and Arizona. For more information about Nephron Pharmaceuticals Corporation, please visit www.nephronpharm.com.

Source: Nephron Pharmaceuticals Corporation